Executive Brief: Competitive Landscape and Strategic Developments in the Artesunate Market
The Artesunate Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.1 billion by 2034, registering a CAGR of 5.8%. This growth trajectory reflects the expanding global burden of malaria and increasing adoption of artemisinin-based combination therapies (ACTs) across endemic regions.
Click to access the Report Study, read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.co....m/industry-report/ar
Suka
Komentar
Membagikan
